H. G. Derigs

429 total citations
11 papers, 264 citations indexed

About

H. G. Derigs is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, H. G. Derigs has authored 11 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Hematology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in H. G. Derigs's work include Hematopoietic Stem Cell Transplantation (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). H. G. Derigs is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Neutropenia and Cancer Infections (2 papers). H. G. Derigs collaborates with scholars based in Germany. H. G. Derigs's co-authors include Christoph Huber, Karin Kolbe, W. E. Aulitzky, S Bhakdi, T Flohr, Patrick Schöffski, Christian Kollmannsberger, A. Gerl, M.A. Kuczyk and Robert Schoch and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Bone Marrow Transplantation.

In The Last Decade

H. G. Derigs

10 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. G. Derigs Germany 6 133 103 67 53 38 11 264
Cheol Won Suh South Korea 9 129 1.0× 71 0.7× 29 0.4× 116 2.2× 43 1.1× 29 275
Nelofar Shafi United States 10 157 1.2× 52 0.5× 47 0.7× 149 2.8× 29 0.8× 16 311
Luis Aversa Argentina 10 73 0.5× 126 1.2× 37 0.6× 71 1.3× 27 0.7× 19 336
Dubravka Sertić Croatia 9 110 0.8× 61 0.6× 34 0.5× 62 1.2× 50 1.3× 24 287
Dong Won Baek South Korea 10 126 0.9× 57 0.6× 49 0.7× 58 1.1× 36 0.9× 52 285
Caroline Jacquy Belgium 7 96 0.7× 91 0.9× 27 0.4× 52 1.0× 21 0.6× 12 229
Seçkin Çağırgan Türkiye 9 67 0.5× 187 1.8× 33 0.5× 35 0.7× 56 1.5× 45 329
Young Bae Choi South Korea 11 68 0.5× 97 0.9× 49 0.7× 23 0.4× 52 1.4× 36 313
Antonella Romanelli Italy 7 127 1.0× 110 1.1× 24 0.4× 132 2.5× 32 0.8× 9 333
Olga Militano United States 12 176 1.3× 247 2.4× 25 0.4× 65 1.2× 55 1.4× 42 446

Countries citing papers authored by H. G. Derigs

Since Specialization
Citations

This map shows the geographic impact of H. G. Derigs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. G. Derigs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. G. Derigs more than expected).

Fields of papers citing papers by H. G. Derigs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. G. Derigs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. G. Derigs. The network helps show where H. G. Derigs may publish in the future.

Co-authorship network of co-authors of H. G. Derigs

This figure shows the co-authorship network connecting the top 25 collaborators of H. G. Derigs. A scholar is included among the top collaborators of H. G. Derigs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. G. Derigs. H. G. Derigs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Vogel, Arndt, Dirk Behringer, H. G. Derigs, et al.. (2021). 1871TiP PLATON – “Platform for Analyzing Targetable Tumor Mutations”: A pilot study. Annals of Oncology. 32. S1255–S1255. 1 indexed citations
2.
Derigs, H. G., et al.. (2008). Stadienorientierte Therapie bei nicht-seminomatösen Hodentumoren. DMW - Deutsche Medizinische Wochenschrift. 119(5). 156–164.
4.
Flohr, T, Karin Kolbe, H. Gamm, et al.. (2002). Rituximab in vivo purging is safe and effective in combination with CD34-positive selected autologous stem cell transplantation for salvage therapy in B-NHL. Bone Marrow Transplantation. 29(9). 769–775. 38 indexed citations
5.
Kollmannsberger, Christian, Oliver Rick, H. G. Derigs, et al.. (2002). Activity of Oxaliplatin in Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer: A Study of the German Testicular Cancer Study Group. Journal of Clinical Oncology. 20(8). 2031–2037. 83 indexed citations
6.
Kreiter, Sebastian, Nils Winkelmann, Peter M. Schneider, et al.. (2001). Failure of sustained engraftment after non-myeloablative conditioning with low-dose TBI and T cell-reduced allogeneic peripheral stem cell transplantation. Bone Marrow Transplantation. 28(2). 157–161. 28 indexed citations
7.
Derigs, H. G.. (2000). In vitro and in vivo purging of B lymphoma cells from stem-cell products using anti-CD20 Abs. Cytotherapy. 2(6). 445–453. 2 indexed citations
8.
Kauczor, Hans‐Ulrich, et al.. (2000). Fokussuche bei neutro- penischem Fieber. Der Radiologe. 40(1). 88–101. 2 indexed citations
9.
Heußel, Claus Peter, Hans‐Ulrich Kauczor, Gudula Heußel, H. G. Derigs, & M. Thelen. (1999). Fokussuche bei neutropenischem Fieber. Der Onkologe. 5(2). 153–167. 1 indexed citations
10.
Kolbe, Karin, et al.. (1997). Infectious complications during neutropenia subsequent to peripheral blood stem cell transplantation. Bone Marrow Transplantation. 19(2). 143–147. 89 indexed citations
11.
Kolbe, Karin, Christian Peschel, Daryl Despres, et al.. (1997). Peripheral blood stem cell (PBSC) mobilization with chemotherapy followed by sequential IL-3 and G-CSF administration in extensively pretreated patients. Bone Marrow Transplantation. 20(12). 1027–1032. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026